Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma

NCT07310173 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

HCC - Hepatocellular Carcinoma

Interventions

DRUG: AST-3424
DRUG: Regorafenib Tablets

Sponsor

Zhejiang Hisun Pharmaceutical Co. Ltd.